FORE Biotherapeutics Names William R. Hinshaw as Chief Executive Officer
PHILADELPHIA–(BUSINESS WIRE)–FORE Biotherapeutics today announced the appointment of William R. Hinshaw as the Chief Executive Officer and Director of the…
Pharmaceuticals, Biotechnology and Life Sciences
PHILADELPHIA–(BUSINESS WIRE)–FORE Biotherapeutics today announced the appointment of William R. Hinshaw as the Chief Executive Officer and Director of the…
CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #LineageCellTherapeutics—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies…
CHARLOTTE, N.C.–(BUSINESS WIRE)–Catawba Research, a prominent global clinical research organization (CRO), welcomes Syed Faridi as its Vice President of Global…
ABRYSVO, a bivalent vaccine, maintained consistently high protective efficacy for both RSV A and RSV B disease through two seasons…
SAN DIEGO, Calif.–(BUSINESS WIRE)–BlossomHill Therapeutics, Inc., a biotechnology company focused on the design and development of small molecule medicines for…
– Highly Differentiated Allogeneic Natural Killer Cell Therapy in Phase 1 Trial, with Initial Data Expected in Second Half of…
DMD patient and advocate Elijah Stacy’s non-profit foundation chooses a targeted dystrophin gene therapy approach using DNA nanoparticles to overcome…
Financing led by Novo Holdings and Forbion Orbis’ platform is first to systematically explore macrocycle chemical space using unique combination…
DUBLIN–(BUSINESS WIRE)–The “Cell Based Assay & High Content Screening Markets. Forecasts by User and Product. With Executive and Consultant Guides.…
– Apraglutide met the primary endpoint of relative change from baseline in actual weekly parenteral support (PS) volume at week…